Pharmacogenetic section, Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, 27709, USA.
Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, 27709, USA.
Sci Rep. 2019 Nov 13;9(1):16734. doi: 10.1038/s41598-019-53139-9.
The androgen receptor (AR) regulates male sexual development. We have now investigated AR homodimerization, hormone-dependent monomerization and nuclear translocation in PC-3 and COS-1 cells, by utilizing mutations associated with the androgen insensitivity syndrome: Pro767Ala, Phe765Leu, Met743Val and Trp742Arg. AR wild type (WT) was expressed as a homodimer in the cytoplasm, while none of these mutants formed homodimers. Unlike AR WT which responded to 1 nM dihydrotestosterone (DHT) to dissociate and translocate into the nucleus, AR Pro767Ala and Phe765Leu mutants remain as the monomer in the cytoplasm. In the crystal structure of the AR LBD homodimer, Pro767 and Phe765 reside closely on a loop that constitutes the dimer interface; their sidechains interact with the Pro767 of the other monomer and with the DHT molecule in the ligand-binding pocket. These observations place Phe765 at a position to facilitate DHT binding to Pro767 and lead to dissociation of the AR homodimer in the cytoplasm. This Pro-Phe Met relay may constitute a structural switch that mediates androgen signaling and is conserved in other steroid hormone receptors.
雄激素受体 (AR) 调节男性性发育。我们利用与雄激素不敏感综合征相关的突变:Pro767Ala、Phe765Leu、Met743Val 和 Trp742Arg,研究了 PC-3 和 COS-1 细胞中 AR 同源二聚体、激素依赖性单体化和核易位。AR 野生型 (WT) 在细胞质中作为同源二聚体表达,而这些突变体均未形成同源二聚体。与对 1 nM 二氢睾酮 (DHT) 反应解离并易位入核的 AR WT 不同,AR Pro767Ala 和 Phe765Leu 突变体仍以单体形式存在于细胞质中。在 AR LBD 同源二聚体的晶体结构中,Pro767 和 Phe765 紧密位于构成二聚体界面的环上;它们的侧链与另一个单体的 Pro767 以及配体结合口袋中的 DHT 分子相互作用。这些观察结果表明,Phe765 处于促进 DHT 与 Pro767 结合并导致 AR 同源二聚体在细胞质中解离的位置。这种 Pro-Phe-Met 接力可能构成介导雄激素信号转导的结构开关,在其他甾体激素受体中保守。